SOURCE: Three Sixty, Inc.

August 21, 2007 08:18 ET

Rockford-Montgomery Labs, Inc. Completes Manufacturing of Its 360 OTC™ Hangover Relief™ and Hangover Relief™ Lite

ATHENS, GA--(Marketwire - August 21, 2007) - Three Sixty, Inc., (PINKSHEETS: TSXT) announces today that its wholly owned subsidiary, Rockford-Montgomery Labs, Inc. (RML), has completed the inaugural manufacturing run of its Food and Drug Administration (FDA) over-the-counter (OTC) approved caplets: 360 OTC™ Hangover Relief™ and 360 OTC™ Hangover Relief™ Lite.

"We have anxiously awaited the completion of our two proprietary drugs since January 2007. The company has missed several anticipated ship dates for the 360 OTC™ Hangover Relief™ and Hangover Relief™ Lite products due to regulatory compliance procedures, increased stability testing and analysis set forth by the FDA and our manufacturer. The company will shift its marketing efforts to sampling and television for the Hangover Relief products, which will create immediate awareness of the 360 OTC™ brand," said Michelle Shearer, CEO of Three Sixty, Inc.

The company has evaluated its marketing program in detail and has decided to invest its marketing dollars into the Hangover Relief products for the remainder of 2007, to include:

1.  A new 360 OTC™ Hangover Relief™ paint scheme on the #36 NASCAR
    Nextel Cup Car, accompanied by sampling during events.

2.  An aggressive television campaign to be aired during the fourth
    quarter of 2007. The commercials will have specific emphasis around
    each of the Holidays, targeted to the youth market.

3.  A sampling campaign at key events and venues during the Holidays,
    including Halloween, Thanksgiving, Christmas and New Years Eve.

4.  A major college sampling campaign accompanied by print advertisement
    in college newspapers, which will target the top 1,200 college
    campuses in the US.

The Hangover Relief products have been well received by retailers and our marketing plan for the fourth quarter will generate additional brand awareness to our core market. The company looks forward to the next stage of the business and implementation of its new marketing strategies.

Rockford-Montgomery Labs, Inc. is a Federal Drug Administration registered drug company (#24432) incorporated in June of 2006 focused on the marketing, sales, production, and distribution of 360 OTC™ brand pharmaceuticals. Rockford-Montgomery has developed the brand 360 OTC™ and has acquired a proprietary formula for the only FDA over-the-counter approved hangover relief medicine.

Three Sixty, Inc. is an acquisition company of branded healthcare and food products. The company targets niche market segments of nationally distributed brands in its respective categories across food, drug, dollar, warehouse, convenience stores and mass merchandisers.

360 OTC™ products include 360 OTC™ Pain Relief and 360 OTC™ Ignite (an alertness-aid), which are available now in approximately 12,121 CVS/pharmacy, Walgreens and Meijer stores nationally.

For more information, please visit the company's website: www.360OTC.com.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact Information

  • Contact:

    Three Sixty, Inc.
    Investor Relations
    Tel: 1-706-354-3725
    Fax: 1-800-927-1593